Background Several small studies on patients with COVID-19 and haematological
malignancies are available showing a high mortality in this population. The Italian …

Background Antiplatelet drugs may prevent recurrent ischemic events after ischemic stroke
but their relative effectiveness and harms still need to be clarified. Within this network meta …

The prognostic assessment of patients with acute pulmonary embolism (PE) is essential to
drive its management. The search for new prognostic factors is a central issue for a more …

Background In recent years resilience has gained clinical relevance in sociological,
psychological, and medical disciplines, and a lot of scales measuring resilience have been …

Lymphoma represents a heterogeneous hematological malignancy (HM), which is
characterized by severe immunosuppression. Patients diagnosed of coronavirus disease …

COVID‐19 is associated with high mortality in patients with haematological malignancies
(HM) and rate of seroconversion is unknown. The ITA‐HEMA‐COV project (NCT04352556) …

Study objective: Although lipid lowering drugs are effective in preventing morbidity and
mortality from cardiovascular events, the extent of their adverse effects is not clear. This …

Objective To compare two different treatment durations of rivaroxaban in patients with
symptomatic isolated distal deep vein thrombosis (DVT). Design Randomised, double blind …

D-dimer assay is used to stratify patients with unprovoked venous thromboembolism (VTE)
for the risk of recurrence. However, this approach was never evaluated since direct oral …

Patients with Philadelphia-negative myeloproliferative neoplasms are at high risk of
thrombotic events (TEs). Predisposing factors have been identified in essential …